Home » Topics » BioWorld Science

BioWorld Science
RSS

CC-220 generally well tolerated in pilot study in systemic lupus erythematosus

May 23, 2019

Novartis describes muscarinic M1-M5 receptor ligands

May 23, 2019

GlaxoSmithKline presents new compounds for HIV infections

May 23, 2019

Heptares Therapeutics discloses new orexin OX1 receptor antagonists

May 23, 2019

Bayer patents alpha2B-adrenoceptor antagonists

May 23, 2019

Kangpu initiates first-in-human study of KPG-818 for SLE

May 23, 2019

SAkuraSky study shows satralizumab reduces relapse of neuromyelitis optica in AQP4-IgG+ patients

May 23, 2019

First-in-human data with BIO89-100 support further development for NASH

May 23, 2019

COX and LOX: For immune response, tolerance beats scorched-earth

May 23, 2019

NX-13: a novel NLRX1-targeting immunometabolic therapeutic for UC

May 23, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Lilly shifts from obesity to narcolepsy with $7.8B Centessa buy
BioWorld
Eli Lilly and Co. plans to buy Centessa Pharmaceuticals plc for $6.3 billion in up-front cash and another potential $1.5 billion through contingent value rights,...